Skip to main content

Miles Johns accepts public warning for violation of UFC Anti-Doping policy

UFC bantamweight failed to obtain a therapeutic use exemption for Adderall.

COLORADO SPRINGS, Colo. – The U.S. Anti-Doping Agency announced today that Miles Johns, of Dallas, Texas, has accepted a public warning for failing to obtain a therapeutic use exemption (TUE) prior to his use of an otherwise prohibited medication. Johns' violation resulted from his use of Adderall, a prescription medication that he used under the care of a physician for a diagnosed medical condition. Johns, 28, has since submitted a TUE application to authorize future use of this medication in sport.

Johns' positive test also falls under the jurisdiction of the Nevada State Athletic Commission, which has resolved the case in accordance with its rules.

USADA conducts the year-round, independent anti-doping program for all UFC athletes. USADA is an independent, non-profit, non-governmental agency whose sole mission is to preserve the integrity of competition, inspire true sport, and protect the rights of clean athletes. In an effort to aid UFC athletes, as well as their support team members, in understanding the rules applicable to them, USADA provides comprehensive instruction on the UFC Anti-Doping Program website regarding the testing process and prohibited substances, how to obtain permission to use a necessary medication, and the risks and dangers of taking supplements, as well as performance-enhancing and recreational drugs.

In addition, the agency manages a drug reference hotline, Drug Reference Online, conducts educational sessions, and proactively distributes a multitude of educational materials, such as the Prohibited List and periodic athlete alerts. Many of the resources available to athletes are provided in multiple languages, including Russian, Spanish, French, Portuguese, Korean, and Japanese.